Receiving a diagnosis of Chronic Myeloid Leukemia (CML) can be frightening, but it is important to understand that the management of this disease is one of the greatest success stories in modern ...

Precision DNA editing gene therapy achieves deep remissions in aggressive leukemia previously considered incurable.

QTX-2101 is an investigational, oral arsenic trioxide therapy that has not yet been approved by any regulatory authority. Its ...

Measurable residual disease-guided ibrutinib-venetoclax therapy achieved undetectable disease in bone marrow in 66.2% of patients with chronic lymphocytic leukemia (CLL) within 2 years compared with ...

At Liv Hospital, specialists emphasize that stem cell therapy isn’t a one-size-fits-all solution. Instead, it is carefully indicated for specific diseases, patient profiles, and treatment ...

A team of researchers found a potential new target for treating diseases associated with human T-cell leukemia virus type 1, including a specific type of leukemia and a neuroinflammatory disease ...

Gleevec, a cancer drug first approved for sale in 2001, has dramatically changed the lives of people with chronic myeloid leukemia. This form of cancer was once regarded as very difficult to combat, ...

Istanbul, Turkey, January 29, 2026 -- Liv Hospital International continues to strengthen its specialized hematology and ...

Joe Ragey didn't think he would live to walk his daughter down the aisle, but thanks to Dr. Kelly Bolton at Washington ...

In a basic science study last year, researchers discovered that taurine, available in energy drinks and as a supplement, ...